Solt DB Biotech Company DB /
Fate Therapeutics

Fate Therapeutics

Operating Overview

Year Founded

2007

Country

United States

Operating Status

Active

Genesis

Startup

Former Name(s)

Incubator or Accelerator

Taxonomy

Bioeconomy Sector

Biopharma

Sector Focus

Drug Development

Tags

Allogeneic

CAR-T

Cell Therapy

Mammalian Cell Culture

Natural Killer Cells

Stem Cells

Equity Type

Public

Stock Symbol

Nasdaq: FATE

Explore